Metalloproteinases as Biomarkers and Sociomarkers in Human Health and Disease

Biomolecules. 2024 Jan 11;14(1):96. doi: 10.3390/biom14010096.

Abstract

Metalloproteinases (MPs) are zinc-dependent enzymes with proteolytic activity and a variety of functions in the pathophysiology of human diseases. The main objectives of this review are to analyze a specific family of MPs, the matrix metalloproteinases (MMPs), in the most common chronic and complex diseases that affect patients' social lives and to better understand the nature of the associations between MMPs and the psychosocial environment. In accordance with the PRISMA extension for a scoping review, an examination was carried out. A collection of 24 studies was analyzed, focusing on the molecular mechanisms of MMP and their connection to the manifestation of social aspects in human disease. The complexity of the relationship between MMP and social problems is presented via an interdisciplinary approach based on complexity paradigm as a new approach for conceptualizing knowledge in health research. Finally, two implications emerge from the study: first, the psychosocial states of individuals have a profound impact on their overall health and disease conditions, which implies the importance of adopting a holistic perspective on human well-being, encompassing both physical and psychosocial aspects. Second, the use of MPs as biomarkers may provide physicians with valuable tools for a better understanding of disease when used in conjunction with "sociomarkers" to develop mathematical predictive models.

Keywords: biomarkers; chronic diseases; complexity paradigm; complexity science; health; interdisciplinary approach; matrix metalloproteinases; psychosocial aspects; sociomarkers; well-being.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Matrix Metalloproteinases
  • Physicians*
  • Proteolysis
  • Zinc

Substances

  • Biomarkers
  • Zinc
  • Matrix Metalloproteinases

Grants and funding

This research received no external funding.